Participate in EIBIR’s Pharmaceutical Trial Survey
EIBIR is inviting interested parties to provide input to the survey on pharmaceutical trials who wish to be considered for potential EIBIR-coordinated projects. The use of imaging as a biomarker in preclinical and clinical studies has gained increasing interest in the pharmaceutical industry. EIBIR is currently in discussion with different pharmaceutical companies to employ the expertise of its members in such studies and to help identify the most suitable partners for specific projects and studies.
Stent Grafts To Treat Blunt Trauma Injuries
Endovascular repair is a better option for individuals who receive highly lethal injuries from high-speed collisions or falls and is shown to save more lives and nearly eliminate paraplegia, a complication of surgical repair for thoracic aortic aneurysms.
States Eric K. Hoffer, Director of vascular and interventional radiology at Dartmouth Medical School, “This minimally invasive interventional radiology technique can decrease the death rate by half and diminish the risk of paraplegia by 75 percent as compared to open surgical repair”.